Cargando…

Iron Deficiency and Deranged Myocardial Energetics in Heart Failure

Among different pathomechanisms involved in the development of heart failure, adverse metabolic myocardial remodeling closely related to ineffective energy production, constitutes the fundamental feature of the disease and translates into further progression of both cardiac dysfunction and maladapta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tkaczyszyn, Michał, Górniak, Krzysztof Michał, Lis, Weronika Hanna, Ponikowski, Piotr, Jankowska, Ewa Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778731/ https://www.ncbi.nlm.nih.gov/pubmed/36554881 http://dx.doi.org/10.3390/ijerph192417000

Ejemplares similares

Monitoring of iron status in patients with heart failure
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Iron deficiency as an emerging therapeutic target in patients stabilized after an episode of acute heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
por: Tkaczyszyn, Michał, et al.
Publicado: (2023)

Drug therapy in elderly heart failure patients
por: Jankowska, Ewa A, et al.
Publicado: (2019)

Iron Deficiency in Heart Failure: A Korea-Oriented Review
por: Jankowska, Ewa A., et al.
Publicado: (2023)

Iron status, catabolic/anabolic balance, and skeletal muscle performance in men with heart failure with reduced ejection fraction
por: Tkaczyszyn, Michał, et al.
Publicado: (2021)

Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2018)

Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
por: Drozd, Marcin, et al.
Publicado: (2016)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Cardiovascular Complications of Viral Respiratory Infections and COVID-19
por: Franczuk, Paweł, et al.
Publicado: (2022)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Iron Status and Short-Term Recovery after Non-Severe Acute Myocarditis: A Prospective Observational Study
por: Franczuk, Paweł, et al.
Publicado: (2023)

Primary Human Cardiomyocytes and Cardiofibroblasts Treated with Sera from Myocarditis Patients Exhibit an Increased Iron Demand and Complex Changes in the Gene Expression
por: Kobak, Kamil A., et al.
Publicado: (2021)

Deranged iron status in psoriasis: the impact of low body mass
por: Ponikowska, Malgorzata, et al.
Publicado: (2015)

Deranged Myocardial Fatty Acid Metabolism in Heart Failure
por: Yamamoto, Tsunehisa, et al.
Publicado: (2022)

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF
por: McEwan, Phil, et al.
Publicado: (2021)

Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency
por: Butler, Javed, et al.
Publicado: (2022)

Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure
por: Nawrocka-Millward, Sylwia, et al.
Publicado: (2021)

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients
por: Martin‐Malo, Alejandro, et al.
Publicado: (2019)

Structural and functional abnormalities in iron-depleted heart
por: Kobak, Kamil A, et al.
Publicado: (2018)

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones
por: Josiak, Krystian, et al.
Publicado: (2014)

Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
por: Filippatos, Gerasimos, et al.
Publicado: (2023)

Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
por: Metra, Marco, et al.
Publicado: (2022)

Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency
por: Anker, Stefan D., et al.
Publicado: (2022)

Iron limitation promotes the atrophy of skeletal myocytes, whereas iron supplementation prevents this process in the hypoxic conditions
por: Kobak, Kamil, et al.
Publicado: (2018)

Biomarkers of Myocardial Injury and Remodeling in Heart Failure
por: Ponikowska, Barbara, et al.
Publicado: (2022)

Health locus of control and the sense of self-efficacy in patients with systolic heart failure: a pilot study
por: Rydlewska, Agnieszka, et al.
Publicado: (2013)

Myocardial Iron Deficiency and Mitochondrial Dysfunction in Advanced Heart Failure in Humans
por: Zhang, Hao, et al.
Publicado: (2022)

Patterns of dyspnoea onset in patients with acute heart failure: clinical and prognostic implications
por: Sokolska, Justyna Maria, et al.
Publicado: (2018)

Multidimensional Approach to Frailty
por: Wleklik, Marta, et al.
Publicado: (2020)

Distinct clinical phenotypes of congestion in acute heart failure: characteristics, treatment response, and outcomes
por: Sokolska, Justyna Maria, et al.
Publicado: (2020)

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency
por: van Veldhuisen, Dirk J., et al.
Publicado: (2017)

Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo (31)P magnetic resonance spectroscopy study
por: Papalia, Francesco, et al.
Publicado: (2022)

Comparison of left ventricular longitudinal systolic function parameters in the prediction of adverse outcome in heart failure with preserved ejection fraction
por: Gozdzik, Anna, et al.
Publicado: (2021)

Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) – Polish population
por: Straburzyńska-Migaj, Ewa, et al.
Publicado: (2015)

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency(†)
por: Ponikowski, Piotr, et al.
Publicado: (2015)

Pro-Inflammatory Derangement of the Immuno-Interactome in Heart Failure
por: Kumar, Pavanish, et al.
Publicado: (2022)

Iron deficiency and cardiovascular disease
por: Savarese, Gianluigi, et al.
Publicado: (2022)

Iron deficiency in heart failure
por: Loncar, Goran, et al.
Publicado: (2021)

Rationale and design of the AMULET study: A new Model of telemedical care in patients with heart failure
por: Krzesiński, Paweł, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jauh5295qivnafc80d5ve7945m